LEMBOREXANT
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | LEMBOREXANT |
| DrugBank ID | DB11951 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 20 |
| DL Predictions (≥0.7) | 15 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| non-small cell lung carcinoma (disease) | TxGNN Knowledge Graph | L5 |
| lung cancer | TxGNN Knowledge Graph | L5 |
| streptococcal pneumonia | TxGNN Knowledge Graph | L5 |
| erectile dysfunction (disease) | TxGNN Knowledge Graph | L5 |
| psychologic dyspareunia | TxGNN Knowledge Graph | L5 |
| premature ejaculation (disease) | TxGNN Knowledge Graph | L5 |
| pulmonary tuberculosis | TxGNN Knowledge Graph | L5 |
| esophageal candidiasis | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11